Atyr Pharma Inc (NASDAQ: ATYR) on Friday, soared 8.08% from the previous trading day, before settling in for the closing price of $4.95. Within the past 52 weeks, ATYR’s price has moved between $1.67 and $7.29.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 34.28% over the past five years. The company achieved an average annual earnings per share of 22.41%. With a float of $95.98 million, this company’s outstanding shares have now reached $97.99 million.
Atyr Pharma Inc (ATYR) Insider Updates
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Atyr Pharma Inc is 2.05%, while institutional ownership is 67.55%. The most recent insider transaction that took place on Mar 17 ’25, was worth 15,000. In this transaction Director of this company bought 3,750 shares at a rate of $4.00, taking the stock ownership to the 9,750 shares. Before that another transaction happened on Feb 04 ’25, when Company’s Chief Financial Officer sold 1,254 for $3.78, making the entire transaction worth $4,740. This insider now owns 31,763 shares in total.
Atyr Pharma Inc (ATYR) Performance Highlights and Predictions
As on 9/30/2024, Multinational firm has announced its last quarter scores, in which it reported -0.23 earnings per share (EPS) for the period falling under the consensus outlook (set at -0.22) by -0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.12 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 22.41% per share during the next fiscal year.
Atyr Pharma Inc (NASDAQ: ATYR) Trading Performance Indicators
Atyr Pharma Inc (ATYR) is currently performing well based on its current performance indicators. A quick ratio of 5.63 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.80, a number that is poised to hit -0.17 in the next quarter and is forecasted to reach -0.65 in one year’s time.
Technical Analysis of Atyr Pharma Inc (ATYR)
Atyr Pharma Inc (NASDAQ: ATYR) saw its 5-day average volume 4.16 million, a positive change from its year-to-date volume of 2.49 million. As of the previous 9 days, the stock’s Stochastic %D was 43.44%.
During the past 100 days, Atyr Pharma Inc’s (ATYR) raw stochastic average was set at 61.12%, which indicates a significant decrease from 66.09% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.34 in the past 14 days, which was lower than the 0.38 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.30, while its 200-day Moving Average is $3.98. Nevertheless, the first resistance level for the watch stands at $5.52 in the near term. At $5.69, the stock is likely to face the second major resistance level. The third major resistance level sits at $5.92. If the price goes on to break the first support level at $5.12, it is likely to go to the next support level at $4.88. Assuming the price breaks the second support level, the third support level stands at $4.71.
Atyr Pharma Inc (NASDAQ: ATYR) Key Stats
Market capitalization of the company is 524.25 million based on 97,987K outstanding shares. Right now, sales total 240 K and income totals -64,020 K. The company made 0 K in profit during its latest quarter, and -19,530 K in sales during its previous quarter.
